'Really reassuring': Israeli study on COVID-19 vaccine finds low risk of reaction among those with history of allergies
About 98 per cent of people with a history of multiple allergies suffered no allergic reactions after receiving a Pfizer-BioNTech vaccine, according to a study conducted in Israel and published recently online in JAMA Network Open.
Of the approximately 2 per cent who did react, none required hospitalization, and symptoms cleared up with medication within a few hours.
“That's really reassuring,” said Dr. Donald Vinh, an immunologist at the MUHC, who explained the study is important because it replicates previous but smaller studies with similar results.
Another point highlighted by the study is that “even if you had a reaction to the first dose of your Pfizer vaccine, you can still go ahead and proceed with your second dose with essentially no risk of having a recurrence of that same allergic reaction,” Vinh said in an interview with CTV News, after reviewing the publication.
Vinh said this brings to the forefront what most studies have shown, “which is concern about allergies should not be a reason to avoid getting the COVID vaccines.”
SAFEGUARDS IN PLACE
To reinforce that advice, Vinh offered encouragement to those with allergies who have held off getting a vaccine thus far, adding vaccines are administered in supervised settings in Quebec.
“They have the trained personnel, the equipment, and the necessary emergency medications in case there's an allergic reaction,” Vinh said.
People are pre-screened for allergies and any contraindications before receiving the shots and are monitored for at least 15 minutes afterward.
Even a serious reaction like anaphylaxis can be treated on the spot, he says.
The Israeli study had a similar framework in place but monitored individuals deemed to be at high risk for two hours following the injections.
The authors concluded that “only patients defined as highly allergic should receive vaccination under medical supervision.”
It’s not known how many Quebecers are shying away from vaccination because of fears related to allergies to food, medications, or environmental factors.
Vinh said it doesn’t appear to be an overwhelming number of people, but is a sizable proportion nonetheless, who should be “reassured,” by this research, and get vaccinated.
ALLERGY FEARS PRESENT AN OBSTACLE
Questions about allergy risks prompted the Sheba Medical Centre in Israel to open a COVID-19 referral centre when the country first rolled out its Pfizer-BioNTech vaccination campaign eight months ago.
“Concerns regarding safety and, particularly, severe allergic reactions to this vaccine are a significant obstacle to implementation of this large immunization program,” the study's authors wrote.
Between December 2020 to February 2021, researchers assessed 8,102 participants for allergy risks according to certain criteria.
There were 429 individuals in the group considered to be at high risk for allergic reactions, which amounted to 5 per cent of the total number of participants.
Women made up the majority of the high-risk group (70.9 per cent), with 63.2 per cent of the entire group reporting prior anaphylaxis.
Following immunization with the first dose, nine women had allergic reactions within the two-hour observation period.
Six of them had minor reactions including skin flushing, tongue or uvula swelling, or a cough that diminished after treatment with an antihistamine.
Three women had anaphylactic reactions 10 to 20 minutes after getting the shot, among other symptoms.
They were treated with several medications including adrenaline and antihistamines. The symptoms resolved with 2 to 6 hours and no one required hospitalization.
When it came time for the second dose, four patients from the highly allergic group had mild allergic reactions.
CTVNews.ca Top Stories
Evacuation order issued for some Fort McMurray neighbourhoods as wildfire nears
Four Fort McMurray neighbourhoods were ordered to evacuate on Tuesday as a wildfire gets closer to the city.
Maximum payout for LifeLabs class-action drops from $150 estimate to $7.86
Canadian LifeLabs customers who filed an application for a class-action settlement began receiving their payments this week, though at a much lower amount than initially expected.
Sask. police seize 1.5M pieces of evidence, lay 60 more charges in child exploitation case
Saskatchewan RCMP have revealed that a historic sexual assault investigation has led to the discovery of alleged crimes against children dating back to 2005.
About 1,000 wildfires confirmed so far this year: Here's a quick look at the situation in Canada
Nearly 1,000 wildfires have burned across Canada so far this year. Here's an overview of the situation in Canada.
'Inappropriate' behaviour shuts down Dublin to New York City portal
Less than a week after two public sculptures featuring a livestream between Dublin, Ireland, and New York City debuted, 'inappropriate behaviour' in real-time interactions between people in the two cities has prompted a temporary shutdown.
American sought after 'So I raped you' Facebook message detained in France on 2021 warrant
An American accused of sexually assaulting a Pennsylvania college student in 2013 and later sending her a Facebook message that said, 'So I raped you,' has been detained in France after a three-year search.
Full List Are these Canada's best restaurants? Annual top 100 list revealed
The annual list of Canada's top restaurants in the country was just released and here are the places that made the 2024 cut.
Tavares scores in OT, rescues Canada from potential upset in 7-6 win over Austria
Captain John Tavares scored 15 seconds into overtime and saved his teammates some embarrassment as Canada held on for a 6-5 win over Austria on Tuesday at the world hockey championship.
BREAKING 'A remarkable time': After 8 years at Toronto Public Health, Dr. Eileen de Villa announces resignation
The doctor who led Toronto through the COVID-19 pandemic as the city’s top public health official is stepping down.